Development and current use of parenteral nutrition in critical care - an opinion paper

Mette M Berger, Claude Pichard, Mette M Berger, Claude Pichard

Abstract

Critically ill patients depend on artificial nutrition for the maintenance of their metabolic functions and lean body mass, as well as for limiting underfeeding-related complications. Current guidelines recommend enteral nutrition (EN), possibly within the first 48 hours, as the best way to provide the nutrients and prevent infections. EN may be difficult to realize or may be contraindicated in some patients, such as those presenting anatomic intestinal continuity problems or splanchnic ischemia. A series of contradictory trials regarding the best route and timing for feeding have left the medical community with great uncertainty regarding the place of parenteral nutrition (PN) in critically ill patients. Many of the deleterious effects attributed to PN result from inadequate indications, or from overfeeding. The latter is due firstly to the easier delivery of nutrients by PN compared with EN increasing the risk of overfeeding, and secondly to the use of approximate energy targets, generally based on predictive equations: these equations are static and inaccurate in about 70% of patients. Such high uncertainty about requirements compromises attempts at conducting nutrition trials without indirect calorimetry support because the results cannot be trusted; indeed, both underfeeding and overfeeding are equally deleterious. An individualized therapy is required. A pragmatic approach to feeding is proposed: at first to attempt EN whenever and as early as possible, then to use indirect calorimetry if available, and to monitor delivery and response to feeding, and finally to consider the option of combining EN with PN in case of insufficient EN from day 4 onwards.

Figures

Figure 1
Figure 1
Effect of nutrition support on total body protein in patients with an acute flare of ulcerative colitis. Conversely to patients with standard care (broken line; mean age 47.6 ± 12.1 years, mean weight 59.4 ± 12.5 kg), ulcerative colitis patients with total parenteral nutrition (TPN; solid black line; mean age 42.6 ± 10.2 years, mean weight 60.8 ± 10.6 kg) received TPN from hospital admission until day 14 after surgery. Patients without TPN showed a rapid body protein loss that fell under the critical threshold before hospital admission, and worsened during the perioperative period. On the contrary, TPN prevented the worsening of protein body loss during the perioperative period and was associated with an earlier restoration (18 weeks earlier) of normal protein stores (mean ± standard deviation). Reproduced with permission from [14].
Figure 2
Figure 2
Milestones in the development of artificial nutrition. Development steps in energy requirements and lipid emulsions (left) and amino acid and glucose steps (right). Adapted with permission from [20].
Figure 3
Figure 3
Relationship between two commonly used equations and the value of energy expenditure. Indirect calorimetry study on day 3 shows that both equations overestimated and underestimated energy expenditure in an unpredictable manner. (A) Pre-enrollment target 25 to 30 kcal/kg actual body weight (BW): arrows show the relation between the calculated energy target used for enrollment (25 or 30 kcal/kg/day) and the measured energy expenditure that became the target used from day 4. (B) Target of the supplemental parenteral nutrition patients recalculated using an equation based on a corrected ideal body weight, age and gender [39], which was used in the Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients (EPaNIC) trial [40] (corrected ideal body weight, age and gender [34] + absolute maximal target of 2,880 kcal).

References

    1. Stapleton RD, Jones N, Heyland DK. Feeding critically ill patients: what is the optimal amount of energy? Crit Care Med. 2007;35(9 Suppl):S535–S540. doi: 10.1097/01.CCM.0000279204.24648.44.
    1. Vincent JL. Give your patient a fast hug (at least) once a day. Crit Care Med. 2005;33:1225–1229. doi: 10.1097/01.CCM.0000165962.16682.46.
    1. Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J. DGEM (German Society for Nutritional Medicine), Ebner C, Hartl W, Heymann C, Spies C, ESPEN (European Society for Parenteral and Enteral Nutrition): ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr. 2006;25:210–223. doi: 10.1016/j.clnu.2006.01.021.
    1. Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest. 2006;129:960–967. doi: 10.1378/chest.129.4.960.
    1. Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med. 2009;35:1728–1737. doi: 10.1007/s00134-009-1567-4.
    1. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr. 2009;28:387–400. doi: 10.1016/j.clnu.2009.04.024.
    1. Anderson CF, MacBurney MM. Application of A.S.P.E.N. clinical guidelines: parenteral nutrition use at a university hospital and development of a practice guideline algorithm. Nutr Clin Pract. 1996;11:53–58. doi: 10.1177/011542659601100253.
    1. Wolfe RR. Regulation of skeletal muscle protein metabolism in catabolic states. Curr Opin Clin Nutr Metab Care. 2005;8:61–65. doi: 10.1097/00075197-200501000-00009.
    1. Plank LD, Hill GL. Energy balance in critical illness. Proc Nutr Soc. 2003;62:545–552. doi: 10.1079/PNS2003259.
    1. Burckart K, Beca S, Urban RJ, Sheffield-Moore M. Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies. Curr Opin Clin Nutr Metab Care. 2010;13:410–416. doi: 10.1097/MCO.0b013e328339fdd2.
    1. Hill GL. Implications of critical illness, injury, and sepsis on lean body mass and nutritional needs. Nutrition. 1998;14:557–558. doi: 10.1016/S0899-9007(98)00045-8.
    1. Iapichino G, Gattinoni L, Solca M, Radrizzani D, Zucchetti M, Langer M, Vesconi S. Protein sparing and protein replacement in acutely injured patients during TPN with and without amino acid supply. Intensive Care Med. 1982;8:25–31. doi: 10.1007/BF01686850.
    1. Biolo G, Ciocchi B, Stulle M, Bosutti A, Barazzoni R, Zanetti M, Antonione R, Lebenstedt M, Platen P, Heer M, Guarnieri G. Calorie restriction accelerates the catabolism of lean body mass during 2 wk of bed rest. Am J Clin Nutr. 2007;86:366–372.
    1. Hill GL. Jonathan E. Rhoads Lecture. Body composition research: implications for the practice of clinical nutrition. J Parenter Enteral Nutr. 1992;16:197–218. doi: 10.1177/0148607192016003197.
    1. Allison SP. The uses and limitations of nutritional support. Clin Nutr. 1992;11:319–330. doi: 10.1016/0261-5614(92)90082-2.
    1. Casaer MP, Langouche L, Coudyzer W, Vanbeckevoort D, De Dobbelaer B, Guiza FG, Wouters PJ, Mesotten D, Van den Berghe G. Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness. Crit Care Med. 2013;41:2298–2309. doi: 10.1097/CCM.0b013e31828cef02.
    1. Doig GS. Parenteral versus enteral nutrition in the critically ill patient: additional sensitivity analysis supports benefit of early parenteral compared to delayed enteral nutrition. Intensive Care Med. 2013;39:981–982. doi: 10.1007/s00134-013-2856-5.
    1. Vinnars E. Arvid Wretlind. Clin Nutr. 2003;22:1–5. doi: 10.1054/clnu.2002.0628.
    1. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery. 1968;64:134–142.
    1. Berger MM. The 2013 Arvid Wretlind lecture: Evolving concepts in parenteral nutrition. Clin Nutr. 2014;ᅟ:ᅟ.
    1. Vinnars E, Hammarqvist F. 25th Arvid Wretlind's Lecture – Silver Anniversary, 25 years with ESPEN, the history of nutrition. Clin Nutr. 2004;23:955–962. doi: 10.1016/j.clnu.2004.06.001.
    1. Berger MM, Chioléro RL, Pannatier A, Cayeux C, Tappy L. A 10-year survey of nutritional support in a surgical ICU: 1986–1995. Nutrition. 1997;13:870–877. doi: 10.1016/S0899-9007(97)00270-0.
    1. Calder PC, Jensen GL, Koletzko BV, Singer P, Wanten GJ. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med. 2010;36:735–749. doi: 10.1007/s00134-009-1744-5.
    1. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 1991;325:525–532. doi: 10.1056/NEJM199108223250801.
    1. Van den Berghe G, Wouters P, Weekers F, Vervaest C, Bruynickx F, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–1367. doi: 10.1056/NEJMoa011300.
    1. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297. doi: 10.1056/NEJMoa0810625.
    1. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–1748. doi: 10.1007/s00134-009-1585-2.
    1. Fong YM, Marano MA, Braber A, He W, Moldawer LL, Bushman ED, Coyle SM, Shires GT, Lowry SF. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg. 1989;210:449–457. doi: 10.1097/00000658-198910000-00005.
    1. Pichard C, Schwarz G, Frei A, Kyle U, Jolliet P, Morel P, Romand JA, Sierro C. Economic investigation of the use of three-compartment total parenteral nutrition bag: prospective randomized unblinded controlled study. Clin Nutr. 2000;19:245–251. doi: 10.1054/clnu.2000.0106.
    1. Dvir D, Cohen J, Singer P. Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr. 2005;25:37–44. doi: 10.1016/j.clnu.2005.10.010.
    1. Villet S, Chioléro RL, Bollmann MD, Revelly JP, Cayeux MC, Delarue J, Berger MM. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005;24:502–509. doi: 10.1016/j.clnu.2005.03.006.
    1. Frankenfield DC, Ashcraft CM. Estimating energy needs in nutrition support patients. J Parenter Enteral Nutr. 2011;35:563–570. doi: 10.1177/0148607111415859.
    1. McClave SA, Lowen CC, Kleber MJ, Nicholson JF, Jimmerson SC, McConnel JW, Jung LY. Are patients fed appropriately according to their caloric requirements? J Parenter Enteral Nutr. 1998;22:375–381. doi: 10.1177/0148607198022006375.
    1. McClave SA, Martindale RG, Kiraly L. The use of indirect calorimetry in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2013;16:202–208. doi: 10.1097/MCO.0b013e32835dbc54.
    1. Cooney RN, Frankenfield DC. Determining energy needs in critically ill patients: equations or indirect calorimeters. Curr Opin Crit Care. 2012;18:174–177. doi: 10.1097/MCC.0b013e3283514bbc.
    1. Faisy C, Guerot E, Diehl JL, Labrousse J, Fagon JY. Assessment of resting energy expenditure in mechanically ventilated patients. Am J Clin Nutr. 2003;78:241–249.
    1. Allard JP, Pichard C, Hoshino E, Stechison S, Fareholm L, Peters WJ, Jeejheebhoy KN. Validation of a new formula for calculating energy requirements of burn patients. J Parenter Enteral Nutr. 1990;14:115–118. doi: 10.1177/0148607190014002115.
    1. Heidegger CP, Berger MM, Graf S, Zingg W, Darmon P, Costanza MC, Thibault R, Pichard C. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013;381:385–393. doi: 10.1016/S0140-6736(12)61351-8.
    1. Jolliet P, Pichard C, Biolo G, Chiolero R, Grimble G, Leverve X, Nitenberg G, Novak I, Planas M, Preiser JC, Roth E, Schols AM, Wernerman J. Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med. 1998;24:848–859. doi: 10.1007/s001340050677.
    1. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506–517. doi: 10.1056/NEJMoa1102662.
    1. Singer P, Anbar R, Cohen J, Shapiro H, Shalita-Chesner M, Lev S, Grozovski E, Theilla M, Frishman S, Madar Z. The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med. 2011;37:601–609. doi: 10.1007/s00134-011-2146-z.
    1. Grau T, Bonet A, Rubio M, Mateo D, Farre M, Acosta JA, Blesa A, Montejo JC, de Lorenzo AG, Mesejo A. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care. 2007;11:R10. doi: 10.1186/cc5670.
    1. Kim H, Stotts NA, Froelicher ES, Engler MM, Porter C. Why patients in critical care do not receive adequate enteral nutrition? A review of the literature. J Crit Care. 2012;27:702–713. doi: 10.1016/j.jcrc.2012.07.019.
    1. Frankenfield D. Validation of an equation for resting metabolic rate in older obese, critically ill patients. J Parenter Enteral Nutr. 2011;35:264–269. doi: 10.1177/0148607110377903.
    1. Crouser ED. Autophagy, the first step towards recovery from critical illness. Crit Care Med. 2013;41:358–359. doi: 10.1097/CCM.0b013e31826bf37c.
    1. Strappazzon F, Campello S, Cecconi F. Non-apoptotic roles for death-related molecules: when mitochondria chose cell fate. Exp Cell Res. 2012;318:1309–1315. doi: 10.1016/j.yexcr.2012.01.027.
    1. Fürst P, Stehle P. Are intravenous amino acid solutions unbalanced? New Horiz. 1994;2:215–223.
    1. Wischmeyer PE. Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol. 2008;24:190–197. doi: 10.1097/MOG.0b013e3282f4db94.
    1. Dechelotte P, Hasselmann M, Cynober L, Allaouchiche B, Coeffier M, Hecketsweiler B, Merle V, Mazerolles M, Samba D, Guillou YM, Petit J, Mansoor O, Colas G, Cohendy R, Barnoud D, Czernichow P, Bleichner G. l-alanyl-l-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006;34:598–604. doi: 10.1097/01.CCM.0000201004.30750.D1.
    1. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone HG. Parenteral l-alanyl-l-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30:2032–2037. doi: 10.1097/00003246-200209000-00013.
    1. Stehle P, Zander J, Mertes N, Albers S, Puchstein C, Lawin P, Fürst P. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989;1:231–233. doi: 10.1016/S0140-6736(89)91254-3.
    1. Grau T, Bonet A, Miñambres E, Piñeiro L, Irles JA, Robles A, Acosta J, Herrero I, Palacios V, Lopez J, Blesa A, Martínez P, Metabolism, Nutrition Working Group, SEMICYUC, Spain The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med. 2011;39:1263–1268. doi: 10.1097/CCM.0b013e31820eb774.
    1. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011;342:d1542. doi: 10.1136/bmj.d1542.
    1. Luo M, Bazargan N, Griffith DP, Estivariz CF, Leader LM, Easley KA, Daignault NM, Hao L, Meddings JB, Galloway JR, Blumberg JB, Jones DP, Ziegler TR. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study. Clin Nutr. 2008;27:297–306. doi: 10.1016/j.clnu.2007.12.003.
    1. Heyland DK, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, Canadian Critical Care Trials Group A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368:1489–1497. doi: 10.1056/NEJMoa1212722.
    1. Rodas PC, Rooyackers O, Hebert C, Norberg A, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012;122:591–597. doi: 10.1042/CS20110520.
    1. Weissman C, Chiolero R, Askanazi J, Gil KM, Elwyn D, Kinney JM. Intravenous infusion of a medium-chain triglyceride-enriched lipid emulsion. Crit Care Med. 1988;16:1183–1190. doi: 10.1097/00003246-198812000-00003.
    1. Calder PC. N-3 fatty acids, inflammation, and immunity – relevance to postsurgical and critically ill patients. Lipids. 2004;39:1147–1161. doi: 10.1007/s11745-004-1342-z.
    1. Heller AR, Rossler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34:972–979. doi: 10.1097/01.CCM.0000206309.83570.45.
    1. Berger MM, Delodder F, Liaudet L, Tozzi P, Schlaepfer J, Chiolero RL, Tappy L. Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr. 2013;97:246–254. doi: 10.3945/ajcn.112.046573.
    1. Calder PC. Lipids for intravenous nutrition in hospitalised adult patients: a multiple choice of options. Proc Nutr Soc. 2013;72:263–276. doi: 10.1017/S0029665113001250.
    1. Pradelli L, Iannazzo S, Zaniolo O, Muscaritoli M, Eandi M. Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total parenteral nutrition therapy for critically ill patients: a discrete event simulation model based on Italian data. Int J Technol Assess Health Care. 2012;28:22–28. doi: 10.1017/S0266462311000705.
    1. Pradelli L, Mayer K, Muscaritoli M, Heller AR. n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care. 2012;16:R184. doi: 10.1186/cc11668.
    1. Doig GS, Simpson F, Early PN. Trial Investigators Group: Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. Clinicoecon Outcomes Res. 2013;5:369–379. doi: 10.2147/CEOR.S48821.
    1. ASPEN Board of Directors and the Clinical Guidelines Task Force Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr. 2002;26:1SA–138SA. doi: 10.1177/014860710202600501.
    1. McClave SA, Heyland DK, Martindale RG. Adding supplemental parenteral nutrition to hypocaloric enteral nutrition: lessons learned from the Casaer Van den Berghe study. J Parenter Enteral Nutr. 2012;36:15–17. doi: 10.1177/0148607111424160.
    1. a) Casaer MP. Wilmer A, Van den Berghe G. Supplemental parenteral nutrition in critically ill patients. The Lancet. 2013;381:1715. doi: 10.1016/S0140-6736(13)61069-7.
    1. Doig GS, Simpson F, Sweetman EA, Finfer SR, Cooper DJ, Heighes PT, Davies AR, O'Leary M, Solano T, Peake S, Early PN investigators of the ANZICS Clinical Trials Group Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA. 2013;309:2130–2138. doi: 10.1001/jama.2013.5124.
    1. Thibault R, Graf S, Clerc A, Delieuvin N, Heidegger CP, Pichard C. Diarrhoea in the intensive care unit: respective contribution of feeding and antibiotics. Crit Care. 2013;17:R153. doi: 10.1186/cc12832.
    1. Pichard C, Attaix D, Baracos VE. A pragmatic and reasonable approach seems the best option to adapt nutrition support to the specific individual patients needs and thus optimize the global care. Curr Opin Clin Nutr Metab Care. 2013;16:241–242. doi: 10.1097/MCO.0b013e328360520e.
    1. Soguel L, Revelly JP, Schaller MD, Longchamp C, Berger MM. Impact of a stepwise introduction of multidisciplinary nutrition protocol with an ICU dietician on the quality of nutritional support and on energy balance. Crit Care Med. 2012;40:412–419. doi: 10.1097/CCM.0b013e31822f0ad7.

Source: PubMed

3
Prenumerera